These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25121555)

  • 1. Discovery of new uncompetitive inhibitors of glucose-6-phosphate dehydrogenase.
    Mercaldi GF; Ranzani AT; Cordeiro AT
    J Biomol Screen; 2014 Dec; 19(10):1362-71. PubMed ID: 25121555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 16-bromoepiandrosterone, an activator of the mammalian immune system, inhibits glucose 6-phosphate dehydrogenase from Trypanosoma cruzi and is toxic to these parasites grown in culture.
    Cordeiro AT; Thiemann OH
    Bioorg Med Chem; 2010 Jul; 18(13):4762-8. PubMed ID: 20570159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding Mode and Selectivity of Steroids towards Glucose-6-phosphate Dehydrogenase from the Pathogen Trypanosoma cruzi.
    Ortiz C; Moraca F; Medeiros A; Botta M; Hamilton N; Comini MA
    Molecules; 2016 Mar; 21(3):368. PubMed ID: 26999093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Strong 3-Nitro-2-Phenyl-
    Carey SM; O'Neill DM; Conner GB; Sherman J; Rodriguez A; D'Antonio EL
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH Producing Enzymes as Promising Drug Targets for Chagas Disease.
    Cordeiro AT
    Curr Med Chem; 2019; 26(36):6564-6571. PubMed ID: 30306853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-6-phosphate dehydrogenase is the target for the trypanocidal action of human steroids.
    Gupta S; Cordeiro AT; Michels PA
    Mol Biochem Parasitol; 2011 Apr; 176(2):112-5. PubMed ID: 21185333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Trypanosoma brucei glucose-6-phosphate dehydrogenase by human steroids and their effects on the viability of cultured parasites.
    Cordeiro AT; Thiemann OH; Michels PA
    Bioorg Med Chem; 2009 Mar; 17(6):2483-9. PubMed ID: 19231202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of a Trypanosoma cruzi glucose-6-phosphate dehydrogenase reveals differences from the mammalian enzyme.
    Mercaldi GF; Dawson A; Hunter WN; Cordeiro AT
    FEBS Lett; 2016 Aug; 590(16):2776-86. PubMed ID: 27391210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of an interface peptide as new inhibitor of human glucose-6-phosphate dehydrogenase.
    Obiol-Pardo C; Alcarraz-Vizán G; Díaz-Moralli S; Cascante M; Rubio-Martinez J
    J Mol Graph Model; 2014 Apr; 49():110-7. PubMed ID: 24637073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
    Alvarez G; Aguirre-López B; Varela J; Cabrera M; Merlino A; López GV; Lavaggi ML; Porcal W; Di Maio R; González M; Cerecetto H; Cabrera N; Pérez-Montfort R; de Gómez-Puyou MT; Gómez-Puyou A
    Eur J Med Chem; 2010 Dec; 45(12):5767-72. PubMed ID: 20889239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits.
    Martinez-Mayorga K; Byler KG; Ramirez-Hernandez AI; Terrazas-Alvares DE
    Drug Discov Today; 2015 Jul; 20(7):890-8. PubMed ID: 25697479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-6-Phosphate Dehydrogenase from the Human Pathogen Trypanosoma cruzi Evolved Unique Structural Features to Support Efficient Product Formation.
    Ortíz C; Botti H; Buschiazzo A; Comini MA
    J Mol Biol; 2019 May; 431(11):2143-2162. PubMed ID: 30930048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.
    Keenan M; Abbott MJ; Alexander PW; Armstrong T; Best WM; Berven B; Botero A; Chaplin JH; Charman SA; Chatelain E; von Geldern TW; Kerfoot M; Khong A; Nguyen T; McManus JD; Morizzi J; Ryan E; Scandale I; Thompson RA; Wang SZ; White KL
    J Med Chem; 2012 May; 55(9):4189-204. PubMed ID: 22536986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors.
    Maluf FV; Andricopulo AD; Oliva G; Guido RV
    Future Med Chem; 2013 Nov; 5(17):2019-35. PubMed ID: 24215344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
    Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
    ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glucose-6-phosphate dehydrogenase from Trypanosoma cruzi: its role in the defense of the parasite against oxidative stress.
    Igoillo-Esteve M; Cazzulo JJ
    Mol Biochem Parasitol; 2006 Oct; 149(2):170-81. PubMed ID: 16828178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose 6-Phosphate Dehydrogenase from Trypanosomes: Selectivity for Steroids and Chemical Validation in Bloodstream
    Ortíz C; Moraca F; Laverriere M; Jordan A; Hamilton N; Comini MA
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33445584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead identification to clinical candidate selection: drugs for Chagas disease.
    Neitz RJ; Chen S; Supek F; Yeh V; Kellar D; Gut J; Bryant C; Gallardo-Godoy A; Molteni V; Roach SL; Khare S; Stinson M; Chatterjee AK; Robertson S; Renslo AR; Arkin M; Glynne R; McKerrow J; Siqueira-Neto JL
    J Biomol Screen; 2015 Jan; 20(1):101-11. PubMed ID: 25281737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.
    Schormann N; Velu SE; Murugesan S; Senkovich O; Walker K; Chenna BC; Shinkre B; Desai A; Chattopadhyay D
    Bioorg Med Chem; 2010 Jun; 18(11):4056-66. PubMed ID: 20452776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruzi.
    Keenan M; Alexander PW; Chaplin JH; Abbott MJ; Diao H; Wang Z; Best WM; Perez CJ; Cornwall SM; Keatley SK; Thompson RC; Charman SA; White KL; Ryan E; Chen G; Ioset JR; von Geldern TW; Chatelain E
    Future Med Chem; 2013 Oct; 5(15):1733-52. PubMed ID: 24144410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.